Skip to main content

Table 3 ICU-specific antimicrobial consumption in DOTs, KAMC-R, 2012–2015

From: Antimicrobial consumption in five adult intensive care units: a 33-month surveillance study

  Medical/ surgical Neuro-surgical Burn Cardio-thoracic Step-down Total
Number of DOTs
 Aminoglycosides 683 146 97 55 477 1458
 Carbapenems 6609 1302 960 725 3161 12,757
 Cephalosporins 1216 480 141 76 542 2455
 Fluoroquinolones 1677 399 209 255 1169 3709
 Piperacillin/Tazobactam 3473 1387 574 1018 1444 7896
 Vancomycin 3438 944 518 539 1570 7009
 Tigecycline 512 8 294 53 296 1163
 Colistin 3002 642 840 183 1693 6360
 Caspofungin 2322 183 167 146 924 3742
 Amphotericin B 218 13 20 0 140 391
 Total 23,150 5504 3820 3050 11,416 46,940
Rates per 1000 patient-days
 Aminoglycosides 35.7 20.0 14.4 7.7 34.4 26.9
 Carbapenems 345.9 178.6 142.0 102.0 228.1 235.7
 Cephalosporins 63.6 65.9 20.9 10.7 39.1 45.4
 Fluoroquinolones 87.8 54.7 30.9 35.9 84.3 68.5
 Piperacillin/Tazobactam 181.8 190.3 84.9 143.3 104.2 145.9
 Vancomycin 180.0 129.5 76.6 75.9 113.3 129.5
 Tigecycline 26.8 1.1 43.5 7.5 21.4 21.5
 Colistin 157.1 88.1 124.3 25.8 122.2 117.5
 Caspofungin 121.5 25.1 24.7 20.5 66.7 69.1
 Amphotericin B 11.4 1.8 3.0 0.0 10.1 7.2
 Total 1211.7 755.2 565.2 429.3 823.7 867.4